1-3 of 3
B. Turlin
Close
Sort by
Journal Articles

Non Invasive Assessment of Hepatic Fibrosis by Measurement of Liver Stiffness in Post Transfusional Iron Overload: Preliminary Results in 15 Patients.

T. Mirault, MD, D. Lucidarme, MD, B. Turlin, MD PhD, Y. Deugnier, MD PhD, P. Brissot, MD PhD, K. Kanaan, MD, J.L. Demory, MD, P. Gosset, MD, P. Vandevenne, MD, A. Charpentier, MD, O. Ernst, MD, PhD, Christian Rose, MD
Journal: Blood
Blood (2006) 108 (11): 3740.
https://doi.org/10.1182/blood.V108.11.3740.3740
Published: 2006
Journal Articles

Iron Chelation Therapy with Deferasirox (Exjade®, ICL670) or Deferoxamine Is Effective in Reducing Iron Overload in Patients with Advanced Fibrosis and Cirrhosis.

E. Angelucci, B. Turlin, D. Canatan, A. Mangiagli, V. De Sanctis, B. Meddeb, C. Rose, D. Soulieres, M. Cunningham, N. Gattermann, C. Ressayre-Djaffer, B. Rabault, J. Ford
Journal: Blood
Blood (2005) 106 (11): 2696.
https://doi.org/10.1182/blood.V106.11.2696.2696
Published: 2005
Journal Articles

Iron Chelation Therapy with Deferasirox (Exjade®, ICL670) or Deferoxamine Results in Reduced Hepatocellular Inflammation and Improved Liver Function in Patients with Transfusion-Dependent Anemia.

P. Brissot, B. Turlin, G.L. Forni, G. Alimena, G. Quarta, D. Selleslag, A. Thompson, F. Locatelli, A. Berretta, M. de Montalembert, C. Ressayre-Djaffer, B. Rabault, J. Ford, D. Alberti
Journal: Blood
Blood (2005) 106 (11): 823.
https://doi.org/10.1182/blood.V106.11.823.823
Published: 2005